Skip to main content

 Scientific publications

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition.

Authors : Paternot S, Raspé E, Meiller C, Tarabichi M, Assié JB, Libert F, Remmelink M, Bisteau X, Pauwels P, Blum Y, Le Stang N, Tabone-Eglinger S, Galateau-Sallé F, Blanquart C, van Meerbeeck JP, Berghmans T, Jean D, Roger PP
Year : 2022
Journal : Mol oncol

Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.

Authors : Spira A, Awada A, Isambert N, Lorente D, Penel N, Zhang Y, Ojalvo LS, Hicking C, Rolfe PA, Ihling C, Dussault I, Locke G, Borel C
Year : 2022
Journal : Front Oncol
Volume : 12
Pages : 981940

Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.

Authors : van Rees DJ, Bouti P, Klein B, Verkuijlen PJH, van Houdt M, Schornagel K, Tool ATJ, Venet D, Sotiriou C, El-Abed S, Izquierdo M, Guillaume S, Saura C, Di Cosimo S, Huober J, Roylance R, Kim SB, Kuijpers TW, van Bruggen R, K van den Berg T, Matlung HL
Year : 2022
Journal : J Immunother Cancer
Volume : 10

Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.

Authors : Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Den Bulck HV, Schrijvers D, Langenaeken C, Specenier P, Jerusalem G, Praet JP, Lobelle JP, Flamaing J, Wildiers H, Decoster L
Year : 2022
Journal : J Geriatr Oncol
Volume : 13
Pages : 1162-1171

Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab.

Authors : Ligorio F, Di Cosimo S, Verderio P, Ciniselli CM, Pizzamiglio S, Castagnoli L, Dugo M, Galbardi B, Salgado R, Loi S, Michiels S, Triulzi T, Tagliabue E, El-Abed S, Izquierdo M, de Azambuja E, Nuciforo P, Huober J, Moscetti L, Janni W, Coccia-Portugal MA, Corsetto PA, Belfiore A, Lorenzini D, Daidone MG, Vingiani A, Gianni L, Pupa SM, Bianchini G, Pruneri G, Vernieri C
Year : 2022
Journal : J Natl Cancer Inst
Volume : 114
Pages : 1720-1727

International consensus on radiotherapy in metastatic non-small cell lung cancer.

Authors : Zhu Z, Ni J, Cai X, Su S, Zhuang H, Yang Z, Chen M, Ma S, Xie C, Xu Y, Li J, Ge H, Liu A, Zhao L, Rao C, Bi N, Hui Z, Zhu G, Yuan Z, Wang J, Zhou W, Rim CH, Navarro-Martin A, Vanneste BGL, Ruysscher D, Choi JI, Jassem J, Chang JY, Kepka L, Käsmann L, Milano MT, Van Houtte P, Suwinski R, Traverso A, Doi H, Suh YG, Noël G, Tomita N, Kowalchuk RO, Sio TT, Li B, Lu B, Fu X
Year : 2022
Journal : Transl Lung Cancer Res
Volume : 11
Pages : 1763-1795

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.

Authors : Laurent A, Marechal R, Farinella E, Bouazza F, Charaf Y, Gay F, Van Laethem JL, Gonsette K, El Nakadi I
Year : 2022
Journal : Thorac Cancer
Volume : 13
Pages : 2699-2710

Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Authors : Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C
Year : 2022
Journal : Target Oncol
Volume : 17
Pages : 497-505

Primary Breast Tuberculosis Mastitis Manifested as Nonhealing Abscess.

Authors : Hoang H, El-Helou E, Pop CF, Shall A, Zaiter M, Naccour J, Nguyen TTH, Ho XD, Nguyen VC
Year : 2022
Journal : Surg J (N Y)
Volume : 8
Pages : e123-e126

Persistent Left Superior Vena Cava Associated with Right Aberrant Subclavian Artery Detected during Totally Implantable Vascular Access Device Insertion.

Authors : El-Helou E, Zaiter M, Shall A, Sleiman Y, Liberale G, Pop CF
Year : 2022
Journal : Surg J (N Y)
Volume : 8
Pages : e117-e122

PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients.

Authors : Gueuning C, Ameye L, Loizidou A, Grigoriu B, Meert AP
Year : 2022
Journal : Support Care Cancer
Volume : 30
Pages : 7635-7643

Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?

Authors : Benkhaled S, Koshariuk O, Van Esch A, Remouchamps V
Year : 2022
Journal : Rep Pract Oncol Radiother
Volume : 27
Pages : 490-499

Heterogeneity of dose distribution in normal tissues in case of radiopharmaceutical therapy with alpha-emitting radionuclides.

Authors : Li WB, Bouvier-Capely C, Saldarriaga Vargas C, Andersson M, Madas B
Year : 2022
Journal : Radiat Environ Biophys
Volume : 61
Pages : 579-596

Psychological factors associated with clinical fear of cancer recurrence in breast cancer patients in the early survivorship period.

Authors : Waroquier P, Delevallez F, Razavi D, Merckaert I
Year : 2022
Journal : Psychooncology
Volume : 31
Pages : 1877-1885

Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study.

Authors : Baré M, Poeta S, Fernandes P, Jourani Y, Otte FX, Van Brussel S, Van Gestel D, Van den Begin R
Year : 2022
Journal : Phys Imaging Radiat Oncol
Volume : 23
Pages : 127-133

Bufalin for an innovative therapeutic approach against cancer.

Authors : Soumoy L, Ghanem GE, Saussez S, Journe F
Year : 2022
Journal : Pharmacol Res
Volume : 184
Pages : 106442

A randomized controlled trial assessing behavioral, cognitive, emotional and physiological changes resulting from a communication skills training in physicians caring for cancer patients.

Authors : Libert Y, Peternelj L, Bragard I, Marchal S, Reynaert C, Slachmuylder JL, Razavi D
Year : 2022
Journal : Patient Educ Couns
Volume : 105
Pages : 2888-2898

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

Authors : Thouvenin J, Alhalabi O, Carlo M, Carril-Ajuria L, Hirsch L, Martinez-Chanza N, Négrier S, Campedel L, Martini D, Borchiellini D, Chahoud J, Lodi M, Barthélémy P, Hasanov E, Hahn AW, Gil T, Viswanathan SR, Bakouny Z, Msaouel P, Asim Bilen M, Choueiri TK, Albiges L, Tannir NM, Malouf GG
Year : 2022
Journal : Oncologist
Volume : 27
Pages : 1041-1047

Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.

Authors : Arboleda B, Bartsch R, de Azambuja E, Hamilton E, Harbeck N, Klemp J, Knauer M, Kuemmel S, Mahtani R, Schwartzberg L, Villarreal-Garza C, Wolff A
Year : 2022
Journal : Oncologist
Volume : 27
Pages : 722-731

Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.

Authors : Rugo HS, Tolaney SM, Loirat D, Punie K, Bardia A, Hurvitz SA, OShaughnessy J, Cortés J, Diéras V, Carey LA, Gianni L, Piccart MJ, Loibl S, Goldenberg DM, Hong Q, Olivo M, Itri LM, Kalinsky K
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 98